Sclerosing encapsulating peritonitis (SEP) associated with peritoneal dialysis (PD) has been reported frequently since its initial description by Gandhi in 1980 (1). The etiology remains elusive: peritonitis might be the most important risk factor, but acetatebased dialysis solutions, chlorhexidine as a disinfectant, and β−blocking drugs have also been implicated as causative agents. Sclerosing...

Encapsulating peritoneal sclerosis (EPS) is an intestinal obstruction syndrome in which peritoneal deterioration and intraperitoneal inflammation result in intestinal adhesions, which are covered with a fibrin capsule and which cause bowel obstruction. Here, we report the case of a patient with EPS suspected to result from the use of icodextrin peritoneal solution. In this patient, peritoneal p...

Qualitative assessments in long-term patients and in those with encapsulating peritoneal sclerosis (EPS) have shown that impaired osmotic conductance is likely a factor contributing to the presence of ultrafiltration failure in those individuals. In the present study, we investigated the value of osmotic conductance, its components LpA and the reflection coefficient sigma, and free water transp...

Sustainable vascular or peritoneal access for dialysis is very important patients undergoing therapy, and trouble occasionally involved with unexpected occurrence of complications. Once occurs, therapy might be discontinued followed by a life-threatening state end-stage kidney disease. Bacterial infection, massive bleeding, thrombosis in hemodialysis acute infectious peritonitis chronic encapsu...

Because of a higher (but improving) incidence of technique failure, peritoneal dialysis (PD) is not thought to equal hemodialysis (HD) for long-term use. Other than death and transplantation, the reasons that patients leave PD include peritonitis, catheter problems, patient burnout, and (in long-duration patients) the development of encapsulating peritoneal sclerosis or ultrafiltration failure....

UNLABELLED Background. Encapsulating peritoneal sclerosis (EPS) is a severe complication of long-term peritoneal dialysis (PD) characterized by the development of an extensive fibrosis of the visceral peritoneum that may eventually lead to intestinal constriction. Its cause remains elusive. Nephrogenic systemic fibrosis (NSF), a disabling disease that can follow gadolinium-based contrast inject...

To the Editor: In patients in whom decannulation of the peritoneal dialysis (PD) catheter is being considered, the laparoscopic method may provide useful information versus traditional methods of removal without visual guidance. Recently, laparoscopic examinations have been increasingly used for PD patients, to confirm a diagnosis of encapsulating peritoneal sclerosis through their ability to r...

Encapsulating peritoneal sclerosis (EPS) is recognized as a serious complication of continuous peritoneal dialysis. A preliminary diagnosis of EPSis usually based on clinical signs and symptoms, which commonly include abdominal pain, nausea, vomiting, anorexia, abdominal fullness, an abdominal mass, bowel obstruction, and radiologic findings, including abdominal roentgenogram, contrast studies,...

Long-term peritoneal dialysis leads to encapsulating peritoneal sclerosis (EPS), which is a rare but often fatal complication. The pathogenesis of EPS is characterized by increased inflammation, neoangiogenesis, epithelial-mesenchymal transition (EMT), and fibrosis. Matrix metalloproteinase 2 (MMP-2), which degrades type IV collagen, plays an important role in pathogenesis. Clinical trials repo...